Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Prospective observational study to evaluate the use of musculoskeletal ultrasonography in rheumatoid arthritis management: the ECHO study.

Stein M, Vaillancourt J, Rampakakis E, Sampalis JS.

Rheumatology (Oxford). 2020 Feb 3. pii: keaa004. doi: 10.1093/rheumatology/keaa004. [Epub ahead of print]

PMID:
32011706
2.

Determinants of biosecurity practices in French duck farms after a H5N8 Highly Pathogenic Avian Influenza epidemic: The effect of farmer knowledge, attitudes and personality traits.

Delpont M, Racicot M, Durivage A, Fornili L, Guerin JL, Vaillancourt JP, Paul MC.

Transbound Emerg Dis. 2020 Jan 20. doi: 10.1111/tbed.13462. [Epub ahead of print]

PMID:
31960594
3.

Assessment of the impact of forestry and leisure activities on wild boar spatial disturbance with a potential application to ASF risk of spread.

Petit K, Dunoyer C, Fischer C, Hars J, Baubet E, López-Olvera JR, Rossi S, Collin E, Le Potier MF, Belloc C, Peroz C, Rose N, Vaillancourt JP, Saegerman C.

Transbound Emerg Dis. 2019 Dec 10. doi: 10.1111/tbed.13447. [Epub ahead of print]

PMID:
31821736
4.

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Vaillancourt J, Turcotte V, Caron P, Villeneuve L, Lacombe L, Pouliot F, Lévesque É, Guillemette C.

Drug Metab Dispos. 2020 Feb;48(2):75-84. doi: 10.1124/dmd.119.088229. Epub 2019 Nov 14.

PMID:
31727674
5.

An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs.

Pope J, Rampakakis E, Vaillancourt J, Bessette L, Lazovskis J, Haraoui B, Sampalis JS.

Rheumatology (Oxford). 2019 Oct 18. pii: kez470. doi: 10.1093/rheumatology/kez470. [Epub ahead of print]

PMID:
31628486
6.

Identification and selection of food safety-related risk factors to be included in the Canadian Food Inspection Agency's Establishment-based Risk Assessment model for Hatcheries.

Racicot M, Comeau G, Tremblay A, Quessy S, Cereno T, Charron-Langlois M, Venne D, Hébert G, Vaillancourt JP, Fravalo P, Ouckama R, Mitevski D, Guerin MT, Agunos A, DeWinter L, Catford A, Mackay A, Gaucher ML.

Zoonoses Public Health. 2020 Feb;67(1):14-24. doi: 10.1111/zph.12650. Epub 2019 Sep 24.

PMID:
31550078
7.

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada.

Rampakakis E, Vaillancourt J, Mursleen S, Sampalis JS.

Pediatr Infect Dis J. 2019 Mar;38(3):253-257. doi: 10.1097/INF.0000000000002251.

8.

Biosecurity practices on foie gras duck farms, Southwest France.

Delpont M, Blondel V, Robertet L, Duret H, Guerin JL, Vaillancourt JP, Paul MC.

Prev Vet Med. 2018 Oct 1;158:78-88. doi: 10.1016/j.prevetmed.2018.07.012. Epub 2018 Jul 26.

PMID:
30220399
9.

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada.

Dang-Tan T, Zhang S, Tavares RV, Stutz M, Ismaila AS, Vaillancourt J, Corriveau D, Stanford RH, Lin X, Nadeau GA, Simidchiev A, Parsons D, Sampalis JS.

Can Respir J. 2017;2017:8184915. doi: 10.1155/2017/8184915. Epub 2017 Jun 20.

10.

Analysis of near-field components of a plasmonic optical antenna and their contribution to quantum dot infrared photodetector enhancement.

Gu G, Vaillancourt J, Lu X.

Opt Express. 2014 Oct 20;22(21):24970-6. doi: 10.1364/OE.22.024970.

PMID:
25401530
11.

Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.

Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Dalal A, Su Z, Sampalis JS.

Curr Med Res Opin. 2014 Jul;30(7):1427-36. doi: 10.1185/03007995.2014.908828. Epub 2014 Apr 14.

PMID:
24666181
12.

Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.

Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS.

Curr Med Res Opin. 2014 Jul;30(7):1417-25. doi: 10.1185/03007995.2014.908827. Epub 2014 Apr 14.

PMID:
24666139
13.

Assessing most practical and effective protocols to sanitize hands of poultry catching crew members.

Racicot M, Kocher A, Beauchamp G, Letellier A, Vaillancourt JP.

Prev Vet Med. 2013 Aug 1;111(1-2):92-9. doi: 10.1016/j.prevetmed.2013.03.014. Epub 2013 Apr 22.

PMID:
23618466
14.

A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study.

Madan M, Vira T, Rampakakis E, Gupta A, Khithani A, Balleza L, Vaillancourt J, Boukas S, Sampalis J, de Carolis E.

Adv Prev Med. 2012;2012:103728. doi: 10.1155/2012/103728. Epub 2012 Dec 6.

15.

Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.

Tan CM, Therien AG, Lu J, Lee SH, Caron A, Gill CJ, Lebeau-Jacob C, Benton-Perdomo L, Monteiro JM, Pereira PM, Elsen NL, Wu J, Deschamps K, Petcu M, Wong S, Daigneault E, Kramer S, Liang L, Maxwell E, Claveau D, Vaillancourt J, Skorey K, Tam J, Wang H, Meredith TC, Sillaots S, Wang-Jarantow L, Ramtohul Y, Langlois E, Landry F, Reid JC, Parthasarathy G, Sharma S, Baryshnikova A, Lumb KJ, Pinho MG, Soisson SM, Roemer T.

Sci Transl Med. 2012 Mar 21;4(126):126ra35. doi: 10.1126/scitranslmed.3003592.

16.

Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence.

Sampalis JS, Adachi JD, Rampakakis E, Vaillancourt J, Karellis A, Kindundu C.

J Bone Miner Res. 2012 Jan;27(1):202-10. doi: 10.1002/jbmr.533.

17.

Risk signals of an influenza pandemic caused by highly pathogenic avian influenza subtype H5N1: spatio-temporal perspectives.

Zhang Z, Chen D, Chen Y, Davies TM, Vaillancourt JP, Liu W.

Vet J. 2012 Jun;192(3):417-21. doi: 10.1016/j.tvjl.2011.08.012. Epub 2011 Sep 22.

PMID:
21944318
18.

Evaluation of the relationship between personality traits, experience, education and biosecurity compliance on poultry farms in Québec, Canada.

Racicot M, Venne D, Durivage A, Vaillancourt JP.

Prev Vet Med. 2012 Feb 1;103(2-3):201-7. doi: 10.1016/j.prevetmed.2011.08.011. Epub 2011 Sep 21.

PMID:
21940059
19.

Evaluation of strategies to enhance biosecurity compliance on poultry farms in Québec: effect of audits and cameras.

Racicot M, Venne D, Durivage A, Vaillancourt JP.

Prev Vet Med. 2012 Feb 1;103(2-3):208-18. doi: 10.1016/j.prevetmed.2011.08.004. Epub 2011 Sep 13.

PMID:
21917344
20.

High-frequency transposition for determining antibacterial mode of action.

Wang H, Claveau D, Vaillancourt JP, Roemer T, Meredith TC.

Nat Chem Biol. 2011 Sep 4;7(10):720-9. doi: 10.1038/nchembio.643.

PMID:
21892185
21.

Description of 44 biosecurity errors while entering and exiting poultry barns based on video surveillance in Quebec, Canada.

Racicot M, Venne D, Durivage A, Vaillancourt JP.

Prev Vet Med. 2011 Jul 1;100(3-4):193-9. doi: 10.1016/j.prevetmed.2011.04.011. Epub 2011 May 24.

PMID:
21605922
22.

Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts.

Khraishi M, MacDonald D, Rampakakis E, Vaillancourt J, Sampalis JS.

Clin Rheumatol. 2011 Jul;30(7):877-85. doi: 10.1007/s10067-011-1692-7. Epub 2011 Feb 2.

PMID:
21287359
23.

Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension.

Hutnik C, Neima D, Ibrahim F, Scott R, Vaillancourt J, Haine D, Sampalis JS, Bastien N, Foucart S.

Clin Ophthalmol. 2010 Jul 21;4:581-90.

24.

Canadian experiences with avian influenza: a look at regional disease control--past, present, and future.

Vaillancourt JP.

Poult Sci. 2009 Apr;88(4):885-91. doi: 10.3382/ps.2008-00334.

25.

Assessment of mortality in older trauma patients sustaining injuries from falls or motor vehicle collisions treated in regional level I trauma centers.

Sampalis JS, Nathanson R, Vaillancourt J, Nikolis A, Liberman M, Angelopoulos J, Krassakopoulos N, Longo N, Psaradellis E.

Ann Surg. 2009 Mar;249(3):488-95. doi: 10.1097/SLA.0b013e31819a8b4f.

PMID:
19247039
26.

Considerations in the development of live biotherapeutic products for clinical use.

Ross JJ, Boucher PE, Bhattacharyya SP, Kopecko DJ, Sutkowski EM, Rohan PJ, Chandler DK, Vaillancourt J.

Curr Issues Mol Biol. 2008;10(1-2):13-6.

27.

Confinement of caspase-12 proteolytic activity to autoprocessing.

Roy S, Sharom JR, Houde C, Loisel TP, Vaillancourt JP, Shao W, Saleh M, Nicholson DW.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4133-8. doi: 10.1073/pnas.0706658105. Epub 2008 Mar 10. Erratum in: Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4852. Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):2047.

28.

Design and initial performance of SHARP, a polarimeter for the SHARC-II camera at the Caltech Submillimeter Observatory.

Li H, Dowell CD, Kirby L, Novak G, Vaillancourt JE.

Appl Opt. 2008 Jan 20;47(3):422-30.

PMID:
18204730
29.

Genotyping of Canadian isolates of fowl adenoviruses.

Ojkic D, Martin E, Swinton J, Vaillancourt JP, Boulianne M, Gomis S.

Avian Pathol. 2008 Feb;37(1):95-100. doi: 10.1080/03079450701805324.

PMID:
18202956
30.
31.

Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones.

Isabel E, Aspiotis R, Black WC, Colucci J, Fortin R, Giroux A, Grimm EL, Han Y, Mellon C, Nicholson DW, Rasper DM, Renaud J, Roy S, Tam J, Tawa P, Vaillancourt JP, Xanthoudakis S, Zamboni RJ.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1671-4. Epub 2007 Jan 11.

PMID:
17251019
32.

T lymphocyte subpopulations diverge in commercially raised chickens.

Bridle BW, Julian R, Shewen PE, Vaillancourt JP, Kaushik AK.

Can J Vet Res. 2006 Jul;70(3):183-90.

33.

Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.

Mellon C, Aspiotis R, Black CW, Bayly CI, Grimm EL, Giroux A, Han Y, Isabel E, McKay DJ, Nicholson DW, Rasper DM, Roy S, Tam J, Thornberry NA, Vaillancourt JP, Xanthoudakis S, Zamboni R.

Bioorg Med Chem Lett. 2005 Sep 1;15(17):3886-90.

PMID:
16023344
34.

Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.

Han Y, Giroux A, Colucci J, Bayly CI, Mckay DJ, Roy S, Xanthoudakis S, Vaillancourt J, Rasper DM, Tam J, Tawa P, Nicholson DW, Zamboni RJ.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1173-80.

PMID:
15686936
35.

Unsupervised learning of a finite mixture model based on the Dirichlet distribution and its application.

Bouguila N, Ziou D, Vaillancourt J.

IEEE Trans Image Process. 2004 Nov;13(11):1533-43.

PMID:
15540460
36.

Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.

Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW.

Nature. 2004 May 6;429(6987):75-9.

37.

A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentation.

Méthot N, Vaillancourt JP, Huang J, Colucci J, Han Y, Ménard S, Zamboni R, Toulmond S, Nicholson DW, Roy S.

J Biol Chem. 2004 Jul 2;279(27):27905-14. Epub 2004 Apr 5.

38.

Solid phase synthesis of selective caspase-3 peptide inhibitors.

Grimm EL, Roy B, Aspiotis R, Bayly CI, Nicholson DW, Rasper DM, Renaud J, Roy S, Tam J, Tawa P, Vaillancourt JP, Xanthoudakis S, Zamboni RJ.

Bioorg Med Chem. 2004 Mar 1;12(5):845-51.

PMID:
14980595
39.

Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors.

Han Y, Giroux A, Grimm EL, Aspiotis R, Francoeur S, Bayly CI, Mckay DJ, Roy S, Xanthoudakis S, Vaillancourt JP, Rasper DM, Tam J, Tawa P, Thornberry NA, Paterson EP, Garcia-Calvo M, Becker JW, Rotonda J, Nicholson DW, Zamboni RJ.

Bioorg Med Chem Lett. 2004 Feb 9;14(3):805-8.

PMID:
14741294
40.

Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics.

Méthot N, Huang J, Coulombe N, Vaillancourt JP, Rasper D, Tam J, Han Y, Colucci J, Zamboni R, Xanthoudakis S, Toulmond S, Nicholson DW, Roy S.

J Exp Med. 2004 Jan 19;199(2):199-207. Epub 2004 Jan 12.

41.

Enhancement of enteropathogenic Escherichia coli pathogenicity in young turkeys by concurrent turkey coronavirus infection.

Pakpinyo S, Ley DH, Barnes HJ, Vaillancourt JP, Guy JS.

Avian Dis. 2003 Apr-Jun;47(2):396-405.

PMID:
12887199
42.

Nicotinyl aspartyl ketones as inhibitors of caspase-3.

Isabel E, Black WC, Bayly CI, Grimm EL, Janes MK, McKay DJ, Nicholson DW, Rasper DM, Renaud J, Roy S, Tam J, Thornberry NA, Vaillancourt JP, Xanthoudakis S, Zamboni R.

Bioorg Med Chem Lett. 2003 Jul 7;13(13):2137-40.

PMID:
12798321
43.

Risk factors associated with poult enteritis mortality syndrome-positive turkey flocks.

Carver DK, Vaillancourt JP, Stringham M.

Avian Dis. 2002 Oct-Dec;46(4):1021-4.

PMID:
12495068
44.

Prevalence of enteropathogenic Escherichia coli in naturally occurring cases of poult enteritis-mortality syndrome.

Pakpinyo S, Ley DH, Barnes HJ, Vaillancourt JP, Guy JS.

Avian Dis. 2002 Apr-Jun;46(2):360-9.

PMID:
12061645
45.

Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.

Han BH, Xu D, Choi J, Han Y, Xanthoudakis S, Roy S, Tam J, Vaillancourt J, Colucci J, Siman R, Giroux A, Robertson GS, Zamboni R, Nicholson DW, Holtzman DM.

J Biol Chem. 2002 Aug 16;277(33):30128-36. Epub 2002 Jun 10.

46.

Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.

Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper DM, Roy S, Hayden MR, Nicholson DW.

Nat Cell Biol. 2002 Feb;4(2):95-105.

PMID:
11788820
47.

Mortality patterns associated with poult enteritis mortality syndrome (PEMS) and coronaviral enteritis in turkey flocks raised in PEMS-affected regions.

Carver DK, Vaillancourt JP, Stringham M, Guy JS, Barnes HJ.

Avian Dis. 2001 Oct-Dec;45(4):985-91.

PMID:
11785903
48.

Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain.

Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst CA, Gan L, Warby S, Wellington CL, Vaillancourt J, Chen N, Gervais FG, Raymond L, Nicholson DW, Hayden MR.

J Biol Chem. 2000 Dec 29;275(52):41299-308.

49.

Bacteriological and histological profile of turkeys condemned for cyanosis.

Mallia JG, Hunter B, Vaillancourt JP, Irwin R, Muckle CA, Martin SW, McEwen SA.

Poult Sci. 2000 Aug;79(8):1194-9.

PMID:
10947191
50.

Poult enteritis complex.

Barnes HJ, Guy JS, Vaillancourt JP.

Rev Sci Tech. 2000 Aug;19(2):565-88. Review.

Supplemental Content

Loading ...
Support Center